DOI QR코드

DOI QR Code

Bacillus sp. SKU31-1가 생산하는 α-Glucosidase 저해제 분리 및 특성 조사

Isolation and Characterization of α-Glucosidase Inhibitor Produced by Bacillus sp. SKU31-1 Strain

  • 김신덕 (서경대학교 화학생명공학과)
  • Kim, Shin-Duk (Department of Chemical and Biological Engineering, Seokyeong University)
  • 투고 : 2014.12.01
  • 심사 : 2014.12.18
  • 발행 : 2014.12.31

초록

미생물 기원의 ${\alpha}$-glucosidase 저해제를 탐색하는 과정에서 토양에서 분리한 균주인 Bacillus sp. SKU31-1 배양액에서 강력한 저해제 compound K을 일련의 크로마토그래피 방법에 의해 분리 정제하였고 $^1H$ NMR, $^{13}C$ NMR, $^1H-^1H$ COSY spectra 분석과 문헌조사를 통해 5-amino-1-hydroxymethyl-1,2,3,4-cyclohexanetetrol로 동정되었다. Compound K의 ${\alpha}$-glucosidase 저해 활성은 $IC_{50}$값이 maltose 기질에서는 $1.9{\mu}M$이고, sucrose 기질 사용시 4.9 mM이었다. Lineweaver Burk plot에 의해 $K_i$값이 0.15 mM 로 강력한 경쟁적 저해제 임이 밝혀졌다.

In the course of screening for ${\alpha}$-glucosidase inhibitor produced by microorganism, the active compound was isolated from the culture filtrate of Bacillus sp. SKU31-1 using a series of chromatography procedures. The structure of the active compound was elucidated as 5-amino-1-hydroxymethyl-1, 2, 3, 4-cyclohexanetetrol on the basis of spectroscopic evidence obtained and comparison with data from the literature. The active compound showed potent inhibitory activity against ${\alpha}$-glucosidase with an $IC_{50}$ value of $1.9{\mu}M$ for maltose and 4.9 mM for sucrose. A Lineweaver-Burk plot indicated that its inhibition of ${\alpha}$-glucosidase was competitive, with a $K_i$ value of 0.15 mM.

키워드

참고문헌

  1. Courageot, M.P., Frenkiel, M.P., Dos Santos, C.D., Deubel, V., and Despres, P. 2000. Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J. Virol. 74, 564-572. https://doi.org/10.1128/JVI.74.1.564-572.2000
  2. Fowler, M.J. 2007. Diabetes Treatment, Part 2: Oral agents for glycemic management. Clin. Diabetes 25, 131-134. https://doi.org/10.2337/diaclin.25.4.131
  3. Heacock, P.M., Hertzler, S.R., Williams, J.A., and Wolf, B.W. 2005. Effects of a medical food containing an herbal a-glucosidase inhibitor on postprandial glycemia and insulinemia in healthy adults. J. Am. Diet. Assooc. 105, 65-71.
  4. Kameda, Y., Asano, N., Yoshikawa, M., Takeuchi, M., Yamaguchi, T., and Matsui, K. 1984. Valiolamine, a new a-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus. J. Antibiotics 37, 1301-1307. https://doi.org/10.7164/antibiotics.37.1301
  5. Kim, S.D. 2013. a-Glucosidase inhibitor from Buthus martensi Karsch. Food Chem. 136, 297-300. https://doi.org/10.1016/j.foodchem.2012.08.063
  6. Playford, R.J., Pither, C., Gao, R., and Middleton, S.J. 2013. Use of the alpha glucosidase inhibitor acarbose in patients with 'Middleton syndrome': normal gastric anatomy but with accelerated gastric emptying causing postprandial reactive hypoglycemia and diarrhea. Can. J. Gastroenterol. 27, 403-404. https://doi.org/10.1155/2013/791803
  7. Wang, C., Sun, Y., Wen, Q., Wang, G., Wang, Y., Qu, Q., Yang, G., and Hu, X. 2010. Novel reagents for quantitative analysis of valiolamine in biological samples by high-performance liquid chromatography with pre-column UV derivatization. Talanta 81, 1613-1618. https://doi.org/10.1016/j.talanta.2010.03.011
  8. Yuasa, H., Takada, J., and Hashimoto, H. 2001. Glycosidase inhibition by cyclic sulfonium compounds. Bioorg. Med. Chem. Lett. 11, 1137-1139. https://doi.org/10.1016/S0960-894X(01)00155-X

피인용 문헌

  1. α-Glucosidase inhibitory activity and protease characteristics produced by Bacillus amyloliquefaciens vol.22, pp.5, 2015, https://doi.org/10.11002/kjfp.2015.22.5.727